MedTrace Logo

Biomarkers in Tissue Samples From Patients With Ewing Sarcoma

NCT01480518 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2015-05-12

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors understand how well patients respond to treatment.

PURPOSE: This research study is studying biomarkers in tissue samples from patients with Ewing sarcoma.

Conditions

  • Sarcoma

Interventions

GENETIC

DNA analysis

GENETIC

comparative genomic hybridization

GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

polymorphic microsatellite marker analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Stephen Lessnick, MD, PhD · University of Utah

Eligibility

Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-01-31
Completion
2012-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480518 on ClinicalTrials.gov